These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32070043)

  • 21. Biodistribution of a carborane-containing porphyrin as a targeting agent for Boron Neutron Capture Therapy of oral cancer in the hamster cheek pouch.
    Kreimann EL; Miura M; Itoiz ME; Heber E; Garavaglia RN; Batistoni D; Rebagliati RJ; Roberti MJ; Micca PL; Coderre JA; Schwint AE
    Arch Oral Biol; 2003 Mar; 48(3):223-32. PubMed ID: 12648560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
    Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer.
    Barth RF; Vicente MG; Harling OK; Kiger WS; Riley KJ; Binns PJ; Wagner FM; Suzuki M; Aihara T; Kato I; Kawabata S
    Radiat Oncol; 2012 Aug; 7():146. PubMed ID: 22929110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Boron neutron capture therapy of cancer: current status and future prospects.
    Barth RF; Coderre JA; Vicente MG; Blue TE
    Clin Cancer Res; 2005 Jun; 11(11):3987-4002. PubMed ID: 15930333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy.
    Wang S; Blaha C; Santos R; Huynh T; Hayes TR; Beckford-Vera DR; Blecha JE; Hong AS; Fogarty M; Hope TA; Raleigh DR; Wilson DM; Evans MJ; VanBrocklin HF; Ozawa T; Flavell RR
    Mol Pharm; 2019 Sep; 16(9):3831-3841. PubMed ID: 31381351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
    Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy.
    Morris GM; Smith DR; Patel H; Chandra S; Morrison GH; Hopewell JW; Rezvani M; Micca PL; Coderre JA
    Br J Cancer; 2000 Jun; 82(11):1764-71. PubMed ID: 10839288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Boron biodistribution for BNCT in the hamster cheek pouch oral cancer model: combined administration of BSH and BPA.
    Garabalino MA; Heber EM; Monti Hughes A; Pozzi EC; Molinari AJ; Nigg DW; Bauer W; Trivillin VA; Schwint AE
    Appl Radiat Isot; 2014 Jun; 88():64-8. PubMed ID: 24360859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rat brain tumor models to assess the efficacy of boron neutron capture therapy: a critical evaluation.
    Barth RF; Yang W; Coderre JA
    J Neurooncol; 2003; 62(1-2):61-74. PubMed ID: 12749703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted drug delivery for boron neutron capture therapy.
    Mehta SC; Lu DR
    Pharm Res; 1996 Mar; 13(3):344-51. PubMed ID: 8692724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.
    Miyatake S; Kawabata S; Kajimoto Y; Aoki A; Yokoyama K; Yamada M; Kuroiwa T; Tsuji M; Imahori Y; Kirihata M; Sakurai Y; Masunaga S; Nagata K; Maruhashi A; Ono K
    J Neurosurg; 2005 Dec; 103(6):1000-9. PubMed ID: 16381186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model.
    Iguchi Y; Michiue H; Kitamatsu M; Hayashi Y; Takenaka F; Nishiki T; Matsui H
    Biomaterials; 2015 Jul; 56():10-7. PubMed ID: 25934274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of cycloaddition reactions to the syntheses of novel boron compounds.
    Zhu Y; Siwei X; Maguire JA; Hosmane NS
    Molecules; 2010 Dec; 15(12):9437-49. PubMed ID: 21178899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of theranostic active-targeting boron-containing gold nanoparticles for boron neutron capture therapy (BNCT).
    Wu CY; Lin JJ; Chang WY; Hsieh CY; Wu CC; Chen HS; Hsu HJ; Yang AS; Hsu MH; Kuo WY
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110387. PubMed ID: 31394419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A critical assessment of boron target compounds for boron neutron capture therapy.
    Hawthorne MF; Lee MW
    J Neurooncol; 2003; 62(1-2):33-45. PubMed ID: 12749701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One step synthesis of
    Kuthala N; Shanmugam M; Yao CL; Chiang CS; Hwang KC
    Biomaterials; 2022 Nov; 290():121861. PubMed ID: 36302304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The New Generation of Particle Therapy Focused on Boron Element (Boron Neutron Capture Therapy; BNCT) -The World's First Approved BNCT Drug].
    Nakashima H
    Yakugaku Zasshi; 2022; 142(2):155-164. PubMed ID: 35110452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proposal of recommended experimental protocols for in vitro and in vivo evaluation methods of boron agents for neutron capture therapy.
    Hattori Y; Andoh T; Kawabata S; Hu N; Michiue H; Nakamura H; Nomoto T; Suzuki M; Takata T; Tanaka H; Watanabe T; Ono K
    J Radiat Res; 2023 Nov; 64(6):859-869. PubMed ID: 37717596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folate receptor-targeted novel boron compound for boron neutron capture therapy on F98 glioma-bearing rats.
    Kanemitsu T; Kawabata S; Fukumura M; Futamura G; Hiramatsu R; Nonoguchi N; Nakagawa F; Takata T; Tanaka H; Suzuki M; Masunaga SI; Ono K; Miyatake SI; Nakamura H; Kuroiwa T
    Radiat Environ Biophys; 2019 Mar; 58(1):59-67. PubMed ID: 30474719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.